We are live on ! Find out more
SNAXW

Stryve Foods, Inc. Warrant

Delisted

SNAXW was delisted on the 4th of February, 2025.

11 hedge funds and large institutions have $112K invested in Stryve Foods, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

8% less funds holding

Funds holding: 1211 (-1)

16% less capital invested

Capital invested by funds: $134K → $112K (-$22.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

SNAXW Hedge Fund Activity: Q4 2022 in Review

11 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Stryve Foods, Inc. Warrant (SNAXW) for Q4 2022, worth a combined $112K — down 16% from $134K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SNAXW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was Cowen and Company, adding an estimated $11.8K. The largest seller was HRT Financial, cutting an estimated $1.01K.

  • 11 institutional investors held Stryve Foods, Inc. Warrant (SNAXW) as of Q4 2022, down from 12 in Q3 2022.
  • Funds reported $112K of Stryve Foods, Inc. Warrant stock for Q4 2022, down 16% quarter-over-quarter.
  • 0 funds opened new Stryve Foods, Inc. Warrant positions in Q4 2022 and 1 closed out, a net change of -1 holder.
  • The largest Stryve Foods, Inc. Warrant buyer in Q4 2022 was Cowen and Company, an estimated $11.8K added.
  • The largest Stryve Foods, Inc. Warrant seller in Q4 2022 was HRT Financial, an estimated $1.01K sold.

Based on aggregated 13F filings for Q4 2022.